Key result
Prolonged cefazolin linked to severe hypoprothrombinemia and bleeding in hemodialysis, reversible with IV vitamin K.
Case Report (n=1)
Prolonged cefazolin therapy in hemodialysis patients with inadequate nutritional intake can lead to severe hypoprothrombinemia and bleeding due to vitamin K deficiency.
Answers are grounded in this paper and cite their sources.
Supports vigilance for vitamin K deficiency bleeding in malnourished hemodialysis patients on prolonged cefazolin; hypothesis-generating and requires prospective confirmation.
This report presents a case of a dialysis patient who developed severe hypoprothrombinemia associated with vitamin K deficiency during prolonged cefazolin (CEZ) therapy. A 73-year-old man undergoing maintenance hemodialysis for end-stage kidney disease due to diabetic nephropathy was hospitalized for purulent tenosynovitis of the right ankle and treated with CEZ. During hospitalization, he had persistent anorexia and experienced recurrent gastrointestinal bleeding. On a non-dialysis day, he developed a subcutaneous hematoma around the arteriovenous fistula. Despite the absence of anticoagulant use, marked prolongation of prothrombin time and activated partial thromboplastin time was observed. Laboratory findings showed reduced activity of vitamin K-dependent coagulation factors and a markedly elevated protein induced by vitamin K absence or antagonist-II level, indicating vitamin K deficiency. Intravenous vitamin K administration and switching the antibiotic from CEZ to ampicillin resulted in rapid improvement of hypoprothrombinemia. This case suggests that in hemodialysis patients, hypoprothrombinemia may develop through cumulative effects of inadequate nutritional intake, prolonged antibiotic exposure, and bleeding-related coagulation factor depletion. Even in the absence of anticoagulant therapy, careful coagulation monitoring is warranted in hospitalized hemodialysis patients receiving prolonged antibiotic treatment.
No takes yet. Share an insight, caveat, or question.
Morimoto et al. (2026) conducted a case report in Severe hypoprothrombinemia and vitamin K deficiency (n=1). Cefazolin was evaluated. Prolonged cefazolin therapy in a hemodialysis patient with inadequate nutritional intake resulted in severe hypoprothrombinemia and bleeding, which rapidly resolved with intravenous vitamin K.
Synapse has enriched 10 related papers. Consider them for comparative context: